The American Kratom Association (AKA) commends the unanimous decision of the New Jersey State Board of Medical Examiners (NJ BME) to endorse S1476, the New Jersey Kratom Protection Act. The NJ BME did so at their January 8th meeting in which they also were presented with a bill opposite S1476: “S3359 – ‘CJ’s Law’; Criminalizes manufacture, sale, and possession of substances containing Kratom.”
“This is an important step to ensure kratom consumers have access to safely formulated and labeled kratom products to reduce the risk of adulterated or contaminated kratom products,” commented Mac Haddow, Senior Fellow on Public Policy. “Equally important, this decision sends a clear message that criminalization is not the solution and stands in stark contrast to the persistent misinformation by anti-kratom trial attorneys and anti-kratom advocates. New Jersey residents and all Americans should be grateful the NJ BME demonstrated that evidence-based science should dictate public policy.”
The AKA will be working closely with New Jersey Legislative leaders to seek passage of S1476 and the House companion legislation so that NJ can join the 13 states that have already enacted this critically important consumer protection legislation.
